Herb Profile

Papaya Leaf

Carica papaya

Papaya Leaf (Carica papaya) carries a Grade C rating — limited evidence.

Last reviewed: 3 sources citedReport a correctionProfile-wide ·C Limited

Use extra caution Claims are dengue/thrombocytopenia adjunct specific and should not replace medical care. Details

Evidence
Limited Evidence
Typical onset
Varies by prep
Safety rating
High caution
Best for
Anti Inflammatory, Antioxidant, Analgesic, Stress resilience
Avoid / review if
Pregnancy, Papaya/Latex Allergy, Severe Dengue Without Medical Care
Papaya Leaf monograph visual
Generated profile category visual

At a glance

From this profile's structured data
Evidence
Grade C
Safety
Claims are dengue/thrombocytopenia-adjunct specific and should not replace medical care.
Profile context
anti-inflammatory, antioxidant, analgesic
Next steps

Continue reading

Safety

Safety & Cautions

Claims are dengue/thrombocytopenia adjunct specific and should not replace medical care. Latex allergy and pregnancy caution are important; monitor bleeding/platelet contexts clinically.

High caution

Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.

  • Interaction-AwareMedication or interaction context is explicitly noted.
  • Anticoagulant CautionBleeding or anticoagulant-adjacent caution language is present.
Detailed safety fields

Pregnancy, breastfeeding, and contraindications

  • Pregnancy
  • Papaya/Latex Allergy
  • Severe Dengue Without Medical Care
  • And Use With Anticoagulants/Antiplatelets Without Supervision.
  • Potential Additive Effects With Anticoagulant/Antiplatelet Therapy
  • Theoretical Interaction With Diabetes Medications.

Safety classifications

  • Interaction-Aware: Medication or interaction context is explicitly noted.
  • Anticoagulant Caution: Bleeding or anticoagulant-adjacent caution language is present.

Full safety note

  • Claims are dengue/thrombocytopenia adjunct specific and should not replace medical care. Latex allergy and pregnancy caution are important; monitor bleeding/platelet contexts clinically.

Safety labels

  • Interaction-Aware
  • Anticoagulant Caution

Evidence-based safety

Caution when combined

Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.

High-Priority Caution

147 flagged pairings

Bleeding / anticoagulant risk

Moderate Caution

110 flagged pairings

Blood-sugar lowering

Evidence

Evidence Summary

Evidence lens

Read as directional context, not settled clinical proof.

LimitedLimited Evidence

Human clinical evidence: Present in source signals

Mechanistic / preclinical: Mechanism mappedInflammatory Signaling Modulation · Oxidative Stress Modulation

Research maturity: Emerging researchLong Term Human Evidence May Be Limited.

Safety boundary: Safety note availableClaims are dengue/thrombocytopenia adjunct specific and should not replace medical care.

This profile cites 3 human studies.

Study design details
Evidence Grade

Grade C: Limited Evidence

Evaluation of methodological rigor, population reach, and evidence alignment.

Design Match
Meta-analysis
Risk of Bias
Low
Consistency
Not assessed
Strongest recorded design is a meta-analysis, drawn from 5 recorded studies, 2 in people.
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials
Clinical Study Summaries (6)2 human evidence sources · 1 human trial · Participant totals not consistently reported · Consistency not yet classifiable

Filter by study class

Showing 6 of 6 studies.

What the evidence actually shows

This table contains 6 structured sources, including 2 human evidence sources; 1 is a human trial.

StudyDesignNDoseDurationPopulationOutcomeResult & magnitudeSource

A systematic review/meta-analysis of 9 dengue studies found platelet-count/hospital-stay signals but judged the evidence low quality and the clinical significance uncertain. This is not proof that papaya leaf treats dengue.

Background
Meta-analysis

Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies.

A systematic review/meta-analysis of 9 dengue studies found platelet-count/hospital-stay signals but judged the evidence low quality and the clinical significance uncertain. This is not proof that papaya leaf treats dengue.PubMed

PMID 41812092

Background
Randomized controlled trial

Randomly assigns participants to interventions or controls, reducing many sources of bias when the trial is conducted well.

A 2026 phase III triple-blind randomized placebo-controlled multicenter trial reported faster platelet recovery with papaya-leaf extract in chemotherapy-induced thrombocytopenia. However, the journal issued an Expression of Concern on July 22, 2026, so the result should not be upgraded as settled high-quality evidence while the concern is unresolved.PubMed

Therapeutic application of Carica papaya leaf extract in the management of human diseases

Singh SP et al. · Daru · 2020

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

PubMed

A Comparative Analysis of Effectiveness of Recombinant Interleukin-11 Versus Papaya Leaf Extract for Treatment of Thrombocytopenia: A Review

Mishra KP et al. · Indian J Clin Biochem · 2023

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

PubMed

Carica papaya Leaf Juice for Dengue: A Scoping Review

Teh BP et al. · Nutrients · 2022

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

PubMed

PMID 42485600

Background
Other / unclear

The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.

JCO Global Oncology published an Expression of Concern on July 22, 2026 for the 2026 papaya-leaf chemotherapy-induced-thrombocytopenia trial. This is a material post-publication evidence change and should be attached directly to the trial record.PubMed

Dosing & Timing

No standardized dose
Preparation specific; use standardized product label for Evidence is strongest for standardized Carica papaya leaf extract/juice in dengue associated thrombocytopenia studies. and require source backed dosage review before therapeutic claims.
How Papaya Leaf works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Papaya Leaf Works

How Papaya Leaf WorksPapaya Leaf acts on biological target pathways via anti inflammatory, leading to anti inflammatory.Papaya LeafBiological TargetBiological pathwayAnti InflammatoryAnti InflammatoryObservable outcomeAntioxidantParallel pathway
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & biological pathways (preclinical)
  • Inflammatory Signaling Modulation
  • Oxidative Stress Modulation

Compare related active botanicals

Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.

Guides that use Papaya Leaf

Condition guides

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Review available sources for Papaya Leaf

Independent database mapping — evaluated separately from safety and efficacy scores.

Check sourcing options

Affiliate disclosure: Shopping links may earn this site a commission at no cost to you. Links are chosen on quality and availability, never commission tiers; safety warnings and evidence ratings stay independent.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?

Free safety checklist

Get the Papaya Leaf research notes

Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.